Author

S. Dillon

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Berlinberg· 1 shared A. Dowdell· 1 shared A. J. Butler· 1 shared A. M. Moon· 1 shared A. Ornelas Sanchez· 1 shared A. P. Davenport· 1 shared A. Stahly· 1 shared A. W. Lohse· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Berlinberg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Microbiota-dependent indole production is required for the development of collagen-induced arthritis

B. Seymour, B. Trent, B. Allen, A. Berlinberg, J. Tangchittsumran, W. Jubair, M. Chriswell, S. Liu, A. Ornelas Sanchez, A. Stahly, E. Alexeev, A. Dowdell, S. Sneed, S. Fechtner, J. Kofonow, , K. A. Kuhn

This study shows that microbiota-dependent indole production is essential for collagen-induced arthritis development and identifies potential therapeutic targets.

bioRxiv · Oct 13, 2023 · PreprintImmunology

FXR inhibition reduces ACE2 expression, SARS-CoV-2 infection and may improve COVID-19 outcome

T. Brevini, M. Maes, G. J. Webb, W. T. H. Gelson, S. Forrest, P. Mlcochova, S. Dillon, S. Varankar, M. Darvish-Damavandi, V. L. Mulcahy, R. E. Kuc, T. L. Williams, V. Galanakis, M. Vila-Gonzalez, O. C. Tysoe, , F. Sampaziotis

This study shows FXR inhibition lowers ACE2 expression, reduces SARS-CoV-2 infection, and correlates with better clinical outcomes in COVID-19.

bioRxiv · Jun 6, 2021 · PreprintMicrobiology